HomeCompareSCLN vs DIVO

SCLN vs DIVO: Dividend Comparison 2026

SCLN yields 17.94% · DIVO yields 6.62%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SCLN wins by $33.3K in total portfolio value
10 years
SCLN
SCLN
● Live price
17.94%
Share price
$11.15
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$64.3K
Annual income
$5,372.32
Full SCLN calculator →
DIVO
DIVO
● Live price
6.62%
Share price
$44.00
Annual div
$2.91
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$31.0K
Annual income
$1,008.47
Full DIVO calculator →

Portfolio growth — SCLN vs DIVO

📍 SCLN pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSCLNDIVO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SCLN + DIVO cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SCLN pays
DIVO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SCLN
Annual income on $10K today (after 15% tax)
$1,524.66/yr
After 10yr DRIP, annual income (after tax)
$4,566.47/yr
DIVO
Annual income on $10K today (after 15% tax)
$562.67/yr
After 10yr DRIP, annual income (after tax)
$857.20/yr
At 15% tax rate, SCLN beats the other by $3,709.27/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SCLN + DIVO for your $10,000?

SCLN: 50%DIVO: 50%
100% DIVO50/50100% SCLN
Portfolio after 10yr
$47.6K
Annual income
$3,190.40/yr
Blended yield
6.70%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SCLN buys
0
DIVO buys
0
No recent congressional trades found for SCLN or DIVO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSCLNDIVO
Forward yield17.94%6.62%
Annual dividend / share$2.00$2.91
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$64.3K$31.0K
Annual income after 10y$5,372.32$1,008.47
Total dividends collected$34.5K$8.4K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: SCLN vs DIVO ($10,000, DRIP)

YearSCLN PortfolioSCLN Income/yrDIVO PortfolioDIVO Income/yrGap
1← crossover$12,494$1,793.72$11,362$661.96+$1.1KSCLN
2$15,463$2,094.42$12,860$702.91+$2.6KSCLN
3$18,968$2,422.55$14,504$743.56+$4.5KSCLN
4$23,073$2,777.26$16,303$783.73+$6.8KSCLN
5$27,845$3,157.31$18,268$823.31+$9.6KSCLN
6$33,355$3,561.10$20,408$862.17+$12.9KSCLN
7$39,677$3,986.73$22,737$900.20+$16.9KSCLN
8$46,886$4,432.07$25,266$937.31+$21.6KSCLN
9$55,063$4,894.76$28,008$973.42+$27.1KSCLN
10$64,290$5,372.32$30,977$1,008.47+$33.3KSCLN

SCLN vs DIVO: Complete Analysis 2026

SCLNStock

SciClone Pharmaceuticals, Inc. is a global biopharmaceutical company. The Company acquires, develops, and commercializes drugs for treating chronic and life-threatening diseases such as cancer, hepatitis B, hepatitis C, cystic fibrosis, and immune system disorders.

Full SCLN Calculator →

DIVOETF

DIVO is an ETF of high-quality large cap companies with a history of dividend and earnings growth, along with a tactical covered call* strategy on individual stocks. DIVO is strategically designed to offer high levels of total return on a risk-adjusted basis.

Full DIVO Calculator →
📬

Get this SCLN vs DIVO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SCLN vs SCHDSCLN vs JEPISCLN vs OSCLN vs KOSCLN vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.